10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,774,532 | +80.7% | 503,625 | +144.7% | 0.01% | +75.0% |
| Q2 2023 | $11,493,869 | +609.1% | 205,807 | +608.3% | 0.00% | +300.0% |
| Q1 2023 | $1,620,979 | +420933.5% | 29,055 | +175.0% | 0.00% | – |
| Q4 2022 | $385 | -99.9% | 10,567 | -20.0% | 0.00% | – |
| Q3 2022 | $377,000 | -75.0% | 13,206 | -60.4% | 0.00% | -100.0% |
| Q2 2022 | $1,509,000 | -74.5% | 33,336 | -57.1% | 0.00% | -50.0% |
| Q1 2022 | $5,911,000 | -39.9% | 77,728 | +17.8% | 0.00% | -33.3% |
| Q4 2021 | $9,832,000 | +5.1% | 65,997 | +2.7% | 0.00% | 0.0% |
| Q3 2021 | $9,356,000 | -21.5% | 64,265 | +5.5% | 0.00% | -25.0% |
| Q2 2021 | $11,926,000 | +100.3% | 60,887 | +84.8% | 0.00% | +100.0% |
| Q1 2021 | $5,955,000 | +208.7% | 32,946 | +141.9% | 0.00% | +100.0% |
| Q4 2020 | $1,929,000 | +160.0% | 13,622 | +128.9% | 0.00% | – |
| Q3 2020 | $742,000 | – | 5,951 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |